ReviewFrontiers in immunology2025

Use of sintilimab in primary adenosquamous carcinoma of the liver results in pathological complete response: a case report and literature review.

Zhiqing Bai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.